Video

FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Fill/Finish

Henrik Herrmann, Executive Director of Technology and Business Development for Drug Product and Finished Goods at FUJIFILM Diosynth Biotechnologies (FDB), will provide an update on the current and future state of FDB’s Drug Product and Finished Goods capabilities. His presentation will highlight FDB’s comprehensive end-to-end CDMO services, detail the latest developments and expansions in Drug Product and Finished Goods capacity, and showcase recent work and strategic partnerships that are helping to advance client programs from development through commercialization.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

FUJIFILM Diosynth Biotechnologies